New toll-like receptor 9 antagonists
AssigneesFraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Yissum Research Development Company of the Hebrew University of Jerusalem
InventorsAnke BURGER-KENTISCHER, Angela MATTES, Maria ZATSEPIN, Amriam GOLDBLUM
Life of this patent
Estimating the term…
Abstract
A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof is provided. The method includes administering to the subject a composition including an active component, wherein the active component is a first compound, a second compound, a third compound, a pharmaceutically acceptable salt thereof, a solvate thereof, or a combination thereof, wherein the first, second, and third compounds include: respectively.
Claims19
A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof, the method comprising:
- administering to the subject a composition comprising an active component,
- wherein the active component is a first compound, a second compound, a third compound, a pharmaceutically acceptable salt thereof, a solvate thereof, or a combination thereof, wherein the first, second, and third compounds comprise:
- respectively.
A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof, the method comprising:
- administering to the subject a composition comprising an active component,
- wherein the active component is selected from the group consisting of:
- pharmaceutically acceptable salts thereof, solvates thereof, and combinations thereof.
Dependencies are inferred from the claim text.